Ken Minkoff, M.D.

CO-OCCURRING DISORDER RESOURCE BIBLIOGRAPHY (2007) - Compiled by Kenneth Minkoff, MD and Christie A. Cline, MD, MBA

•  American Association of Community Psychiatrists, Level of Care Utilization System (LOCUS 2.001), Dallas , AACP 2000.

•  American Association of Community Psychiatrists, Principles for the care and treatment of individuals with co-occurring psychiatric and substance disorders. Dallas, AACP 2000. (AACP web site: www.commpsych.org )

•  Addiction Technology Transfer Center Network. The Change Book: a blueprint for technology transfer. 2004. www.nattc.org/changebook

•  American College of Emergency Physicians. Clinical Policy: Critical issues in the diagnosis and management of the adult psychiatric patient in the emergency department. April, 2005

•  American Society of Addiction Medicine. Patient Placement Criteria 2 ND Edtion Revised. Washington , DC , ASAM. 2001.

•  Alexander MJ. Women with co-occurring disorders: an emerging profile of vulnerability. Am. J. Orthopsychiatry. (1996) 66:61-70.

•  Barreira, P, Espey, E, et. al.. Linking substance abuse and serious mental illness service delivery systems: initiating a statewide collaborative. Journal of Beh Health Serv Res, 2000. 27: 107-13.

•  Bastiaens, L, Francis G, & Lewis, K. The RAFFT as a screening tool for adolescent substance use disorders. Am. J. Addictions. (2000) 9:10-16.

•  Bellack AS , Bennett ME, & Gearon JS. Behavioral treatment for substance abuse in people with SPMI. (2007) Routledge , New York ..

•  Bellack AS & DiClemente CC. Treating substance abuse among patients with schizophrenia. Psych Services (1999) 50:75-80.

•  Bogenschutz MP. Specialized 12-step programs and 12-step facilitation for the dually diagnosed. CMHJ (2005) 41:7-20.

•  Boyle P & Weider B. Creating and sustaining IDDT programs: lessons learned in Ohio . J. Dual Dx. (2007) 3:103-110.

•  Broner N, et al. Effects of diversion on adults with co-occurring mental illness and substance abuse: outcomes from a national multi-site study. Behav Sci & the Law (2004) 22:519-41

•  Brunette, M, & Drake, RE. Gender differences in homeless persons with schizophrenia and substance abuse. Comm MH Journal (1998).34:627-33

•  Bucciarelli C. Addicted and Mentally Ill. Stories of courage, hope, and empowerment. Binghamton , Haworth Press. 2005.

•  Burton Donna, Cox Arthur, Fleisher-Bond Margo, Cross Training for Dual Disorders; A Comprehensive Guide to Co-occurring Substance Use and Psychiatric Disorders. New York , NY . Vantage Press. 2001.

•  Canadian Centre on Substance Abuse. Core competencies for Canada 's Substance Abuse Field, version 1.0. CCSA. Ottawa 2007. www.ccsa.ca

•  Carey KB, Leontieva, L, et al. Adapting motivational interventions for comorbid schizophrenia and alcohol use disorders. Clin Psychol. Sci. Prac. (2007) 14:39-57.

•  Carroll KM & Onken LS. Behavioral therapies for drug abuse. Am. J. Psychiat. (2005). 162 (8): 1452-60.

•  Center For Substance Abuse Treatment. A guide to substance abuse services for primary care clinicians. Treatment Improvement Protocol #24. CSAT, Washington, 1997

•  Center For Substance Abuse Treatment. Enhancing Motivation for Change in Substance Abuse Treatment. Treatment Improvement Protocol #35. CSAT, Washington, 1999.

•  Center For Substance Abuse Treatment. Substance Abuse Treatment for persons with HIV/AIDS. Treatment Improvement Protocol #37. CSAT, Washington, 2000.

•  Center for Substance Abuse Treatment. Substance Abuse Treatment for Individuals with Co-occurring Disorders. Treatment Improvement Protocol #42, CSAT, Washington, 2005

•  Center For Substance Abuse Treatment. Detoxification and SA Treatment. Treatment Improvement Protocol #45. CSAT, Washington, 2006 www.ncadi.samhsa.gov .

•  Center For Substance Abuse Treatment. Substance Abuse Treatment for persons with co-occurring disorders (TIP 42) inservice training. CSAT, 2007 www.kap.samhsa.gov

•  Centre for Addiction and Mental Health (CAMH). Best Practices: concurrent mental health and substance use disorders. Ottawa : Health Canada . 2001

•  Centre for Addiction and Mental Health (CAMH) Beyond the label: an educational kit for addressing stigma for people with concurrent disorders. www.camh.net . (2005) .

•  Centre for Addiction and Mental Health (CAMH). Navigating screening options for concurrent disorders. (cd-rom). www.camh.net . (2006)

•  Chichester C, Hornsby H, et al. Final report and evaluation: a project to establish a more welcoming system for people with co-occurring disorders in Maine . Hornsby-Zeller: Portland , ME (2006).

•  Cline, C and Minkoff K, Substance Abuse and Mental Health Services Administration. A Strength Based Systems Approach to Creating Integrated Services for Individuals with Co-occurring Psychiatric and Substance Abuse Disorders-A Technical Assistance Document. NMDOH/BHSD Dec. 2002.

•  Co-occurring Center for Excellence (COCE): Overview Papers: 1. Definitions and Terms relating to Co-occurring disorders. 2. Screening, Assessment, and Treatment Planning. 3. Overarching Principles to Address Co-occurring Disorders. 4. Addressing Co-occurring Disorders in Non-Traditional Settings. 5. Understanding Evidence Based Practice for Co-occurring Disorders. SAMHSA, Rockville , MD. 2006-2007. www.coce.org .

•  Daley Dennis, Moss Howard, Dual Disorders: Counseling Clients with Chemical Dependency and Mental Illness, 3 rd ed. Center City , MN . Hazelden. 2002.

•  Daley Dennis, Coping with Dual Disorders: Addiction and Psychiatric Illness, Center City , MN . Hazelden. 2003.

•  Daley DC & Spears J. A family guide to coping with dual disorders. Center City , MN : Hazelden. 2003

•  Delos Reyes CM & Ronis RJ. Statewide Implementation of Integrated Dual Disorder Treatment. The psychiatrist's role. J. Dual Dx. (2006) 3:129-34l

•  Double Trouble in Recovery. www.doubletroubleinrecovery.org .

•  Drake RE. Management of substance use disorder in schizophrenia patients: current guidelines. CNS Spectr 12:10 (Suppl 17) 27-34 (2007).

•  Drake, RE, Bartels, SJ, et. al.. Treatment of substance abuse in severely mentally ill patients. J. Nervous Mental Disease (1993) 181:606-11.

•  Drake RE, Burnette, Mary, eds. Integrated Dual Disorders Treatment (IDDT) Toolkit. SAMSHA. 2001.

•  Drake, RE, Essock, SM, et. al.. Implementing Dual Diagnosis services for clients with severe mental illness. Psych Services (2001) 52(4):469-476.

•  Drake, RE, Mercer-McFAdden, C, et. al. (eds.) Readings in Dual Diagnosis. International Association of Psychosocial Rehabilitation Services. Columbia , MD. 1998.

•  Drake RE, Mueser KT, & Brunette MF. Management of persons with co-occurring severe mental illness and substance use disorder: program implications. World Psych 2007;6:131-6.

•  Dual Diagnosis World Services. Dual Diagnosis Anonymous for Teens. (2002). Dual Diagnosis World Services, San Bernardino , CA . www.ddaworldwide.org

•  Dual Recovery Anonymous. www.draonline.org

•  Ekleberry, SC. Co-occurring Disorders: Personality Disorders and Addiction. In Press (2008). Also: sekleberry@hotmail.com . Materials available on Dual Diagnosis Website: www.toad.net/~arcturus/dd/ddhome.htm .

•  El-Guebaly N, et al. Smoking cessation approaches for persons with mental illness or addictive disorders. Psych Services (2002) 53:1166-70.

•  Elliott DE, et al. Trauma-informed or trauma-denied: principles and implementation of trauma informed services for women (with co-occurring disorders). J. Comm Psychol. (2005) 3:461-77.

•  Essock SM, Mueser KT, et al. Comparison of ACT and standard case management for delivering integrated treatment. Psych Services (2006) 57:185-95.

•  Evans K & Sullivan JM. Treating Addicted Survivors of Trauma. Guilford , New York . 1995.

•  Evans K & Sullivan JM. Dual diagnosis: Counseling the Mentally Ill Substance Abuser. 2 nd Edition. Guilford , New York . 2001.

•  Federation of Families for Children's Mental Health. Blamed and ashamed: the treatment experiences of youth with co-occurring disorders and their families. October, 2000.

•  Finkelstein N & Markoff LS. The Women Embracing Life and Living (WELL) Project. Using the relational model to develop integrated systems of care for women with alcohol/drug use and mental health disorders with histories of violence. Alcoholism Treatment Quarterly (2004). 22: 63-80.

•  Fornili K & Haack MR. Promoting early intervention for substance use disorders through interdisciplinary education for health professionals. J. Add. Nurs. (2005) 16:153-60.

•  Foundation Associates, Making Medication Part of Your Life (one of a series of pamphlets and workbooks). Nashville , TN. Foundation Associates. 2003. www.dualdiagnosis.org

•  Frisman LK, et al. Outcomes of court based jail based diversion programs for people with co-occurring disorders. J. Dual Dx (2006): 2(2):5-24.

•  Gagne C, White W, & Anthony W. Recovery: A common vision for the fields of mental health and addictions. Psych Rehab J (2007) 31:32-37.

•  Geppert C, Minkoff K, Psychiatric Disorders and Medications, Center City , MN . Hazelden. 2003.

•  Geppert C, Minkoff K, Psychiatric Medications and Recovery from Co-Occurring Disorders, Center City , MN . Hazelden. 2003.

•  Godley SH, Finch M, et. al.. Case management for dually diagnosed individuals involved in the criminal justice system. J. Sub Ab. Treatment.(2000) 18:137-48.

•  Grant BF et al. Co-occurrence of 12 month alcohol and drug use and personality disorders in the US . Arch Gen Psych (2004) 61:361-8.

•  Goldfinger, SM, Shute, RK, et. al.. Housing placement and subsequent days homeless among formerly homeless adults with mental illness. Psych Services (1999) 50:674-9.

•  Hamilton, T. & Samples, P. The 12 Steps and Dual Disorders. Hazelden, Center City , MN . 1995.

•  Harris M. Trauma Recovery and Empowerment Manual. Free Press. New York . 1998.

•  Health Management Associates. Integrating publicly funded physical and behavioral health services. Final Report for RWJ. Lansing . 2007.

•  Hendrickson, EL, Schmal MS, & Ekleberry SC. Treating Co-Occurring Disorders: A Handbook for Mental Health and Substance Abuse Professionals 2005.

•  Hendrickson EL. Designing, implementing, and managing treatment services for individuals with co-occurring disorders. Binghamton ; Haworth Press. 2006.

•  Henwood B & Padgett DK Re-evaluating the self-medication hypothesis among the dually diagnosed. Am. J. Addictions (2007) 16:160-65.

•  Hoffman NG, Mee-Lee D, & Schulman G. DAPPER- Dimensional assessment for patient engagement and recovery. Evince Clinical Assessments: Smithfield RI (2004)

•  Illinois Alcohol and Other Drug Abuse Professional Certification Association. The Illinois standard for board registered MI/SA I/II. IAODAPCA, Springfield , IL . 1998.

•  Institute of Medicine Committee on Crossing the Quality Chasm: adaptation top mental health and addictive disorders. Improving the quality of health care for mental and substance use conditions: quality chasm series. National Academy of Sciences 2006. www.nap.edu .

•  Kalivas, P & Volkow, N. Addiction: a brain disorder of motivation and control. Am. J. Psych, 2005 162(8).

•  Kerwin,M, WalkerSmith K, & Kirby K. Comparative analysis of state requirements for the training of substance abuse and mental health counselors. J Sub Ab Tr. (2006) 30:173-181.

•  Kessler RC, Nelson CB et. al.. The epidemiology of co-occurring addictive and mental disorders. Am. J. Orthopsychiatry. (199.6) 66:17-31.

•  Kleinpeter C, et al. Providing recovery services for offenders with co-occurring disorders. J. Dual Dx. (2006) 3:59-86.

•  Knoll J. A tale of two crises: mental health treatment in corrections. J Dual Dx (2006) 3:7-22.

•  Leshner AI. Addiction is a brain disease, and it matters. Science (1997) 278:45-7

•  Lucksted, A, Dixon , L, & Sembly, JB. A focus group pilot study of tobacco smoking among psychosocial rehabilitation patients. Psych Services (2000). 51:1544-8.

•  Martino S, Carroll K et al: Dual diagnosis motivational interviewing: a modification for substance abusing patients with psychotic disorders. J. Sub Ab Tx (2002) 23:297-308.

•  McGovern M, et al. Assessing the dual diagnosis capability of addiction treatment programs: the DDCAT. J. Dual Dx (2007) 3:111-124.

•  McLellan AT et al. Drug dependence, a chronic medical illness: implications for treatment, insurance, and outcomes evaluation. JAMA (2000) 284:1689-95

•  McLellan AT et al. Improving continuity of care in a public addiction system with clinical case management. Am J Addictions (2005) 14:426-40.

•  McKillip, R. The Basics: a curriculum for co-occurring mental health and substance use disorders. 2004. Available from author: www.mckillipbasics.com

•  Mee-Lee, D. Tips and Topics: a series on co-occurring disorders. www.dmlmd.com

•  Mercer-McFadden C, Drake RE, et. al.. Substance Abuse Treatment for People with Severe Mental Disorders: a program manager's guide. NH-Dartmouth Psychiatric Research Center , Concord , NH . 1998.

•  Mid-America Addiction Technology Transfer Center . A Collaborative Response: Addressing the needs of consumers with co-occurring substance use and mental health disorders. (including: Psychotherapeutic Medications 2006: what every counselor should know). Kansas City , Missouri , 2006. Web site: www.mattc.org ., e-mail: atc@mattc.org , phone: 816-482-1100.

•  Miller, WR & Rollnick S. Motivational Interviewing, 2 nd Edition. Guilford Press, New York . 2002.

•  Min SY, et al. Peer support for persons with co-occurring disorders and community tenure. Psych Rehab J. (2007) 30:207-13.

•  Minkoff, K. MIDAS: Mental illness drug and alcohol screening tool. 2001. Unpublished.

•  Minkoff, K. Chair. CMHS Managed Care Initiative Panel on Co-occurring Disorders Co-occurring psychiatric and substance disorders in managed care systems: standards of care, practice guidelines, workforce competencies, and training curricula. Center for Mental Health Policy and Services Research. Philadelphia , 1998. Web site: www.med.upenn.edu/cmhpsr

•  Minkoff, K. Developing standards of care for individuals with co-occurring psychiatric and substance disorders. Psych Services. 2001; 52:597-99.

•  Minkoff, K. An integrated model for the management of co-occurring psychiatric and substance disorders in managed care systems. Dis. Mgt & Health Outcomes (2000).8(5):251-7.

•  Minkoff K. Behavioral Health Recovery Management Service Planning Guidelines and CCISC Psychopharmacology Practice Guidelines for co-occurring psychiatric and substance disorders. www.bhrm.org , 2005.

•  Minkoff, K. Program components of a comprehensive integrated care system for serious mentally ill patients with substance disorders. In: Minkoff K, Drake RE, eds. Dual Diagnosis of Major Mental Illness and Substance Disorder. New Directions for Mental Health Services, No 50. San Francisco , CA. Jossey-Bass, 1991, pp 13-27.

•  Minkoff, K. What is Integration, Part I: (System and Services) Journal of Dual Diagnosis (2006) 2 (4): 133-144; What is Integration, Part II: (Programs and Practices). J. Dual Dx. (2007) 3 (1):149-158. What is Integration, Part III. (Clinicians and Competencies) J Dual Dx (2007) 3 (3/4):187-97.

•  Minkoff K. Dual Diagnosis Enhanced Programs: Journal of Dual Diagnosis (2008), in press.

•  Minkoff, K & Cline, C. CODECAT™ (Version 1): Co-occurring Disorders Educational Competency Assessment Tool/Clinician Core Competencies for Co-occurring Psychiatric and Substance Abuse Disorders, Zialogic 2001; COMPASS™ (Version 1): Co-morbidity Program Audit and Self-Survey for Behavioral Health Services/Adult and Adolescent Program Audit Tool for Dual Diagnosis Capability, Zialogic 2001; CO-FIT100™ 100 (Version 1): CCISC Outcome Fidelity and Implementation Tool, Zialogic 2002.

•  Minkoff K & Cline C, Scope of Practice Guidelines for Addiction Counselors Treating the Dually Diagnosed. Counselor. 2003; 4: 24 -27.

•  Minkoff K & Cline C, Changing the World: the design and implementation of comprehensive continuous integrated systems of care for individuals with co-occurring disorders. Psychiat Clin N Am 2004, 27: 727-743.

•  Minkoff K & Cline C, Developing welcoming systems for individuals with co-occurring disorders: the role of the Comprehensive Continuous Integrated System of Care model. J Dual Diagnosis 2005, 1:63-89

•  Minkoff K &. Cline C, Dual diagnosis capability: moving from concept to implementation. Journal of Dual Diagnosis (2006): 2(2):: 121-134

•  Minkoff K & Cline C. Scope of practice guidelines for rehabilitation professionals working with individuals with co-occurring mental health and substance disorders. Rehab Review. Summer, 2006: 22-25.

•  Minkoff, K & Drake, RE. Homelessness and dual diagnosis. In Lamb, HR (ed). Treating the Homeless Mentally Ill. Washington , DC , APPI. 1994. 221-35.

•  Minkoff, K & Regner, J. Innovations in integrated dual diagnosis treatment in public managed care: the Choate dual diagnosis case rate program. J.Psychoactive Drugs. (1999). 31(1): 3-11.

•  Minkoff K, Zweben J, Rosenthal R, & Ries R. Development of service intensity criteria and program categories for individuals with co-occurring disorders. J. Add. Dis (2003) 22 (supp 1):113-29.

•  Montoya ID & Vocci F. Medications development for the treatment of nicotine dependence in individuals with schizophrenia. J. Dual Dx (2007) 3 (3/4) 113-50.

•  Morrissey JP et al. Twelve month outcomes of trauma-informed interventions for women with co-occurring disorders. Psych Services (2005). 36:1213-1222.

•  Morrissey JP et al. Extending assertive community treatment to criminal justice settings. CMHJ (2007) 43:527-44.

•  Mueser, KT, Bennett, M, & Kushner, MG. Epidemiology of substance use disorders among persons with chronic mental illnesses. In. Lehman, A & Dixon, LJ. Double Jeopardy. Chronic Mental Illness and Substance Use Disorders. Harwood Academic Publishers, Chur , Switzerland .. 1995.

•  Mueser, KT, Drake, RE, & Wallach , MA . Dual diagnosis: a review of etiological theories. Addictive Behaviors (1998) 23:717-34.

•  Mueser KT, Drake RE, et al. Psychosocial interventions for adults with severe mental illnesses and co-occurring SUD: a review. J. Dual Dx. (2005) 1(2);57-82.

•  Mueser KT & Fox L. A family intervention program for dual disorders (FIDD). Community MHJ. (2002) 38:253-70

•  Mueser, KT & Noordsy, DL. Group treatment for dually diagnosed clients. In Drake, RE & Mueser, KT. Dual diagnosis of major mental illness and substance disorder. Part 2. Jossey-Bass, San Francisco . 1996.

•  Mueser, KT, Noordsy, DL, Drake, RE, Fox, L. Integrated Treatment for Dual Disorders: A Guide to Effective Practice. New York , NY : Guilford Press, 2003.

•  Najavits L, Seeking Safety, A Treatment Manual for PTSD and Substance Abuse. New York , NY : Guilford Press. 2002.

•  NASMHPD/NASADAD. The new conceptual framework for co-occurring mental health and substance use disorders. Washington , DC . NASMHPD 1998.

•  NASMHPD/NASADAD. Financing and marketing the new conceptual framework. Washington, NASMHPD. 2000

•  NASMHPD State Medical Directors Council. Integrating behavioral health and primary care services: opportunities and challenges for state mental health authorities. 2004. www.nasmhpd.org

•  National Center for Trauma-Informed Care. http://mentalhealth.samhsa.gov/ncitc/ .

•  National Council for Community Behavioral Healthcare. Behavioral health/primary care integration: draft background paper. 2002. www.nccbh.org

•  National GAINS Center . The Courage to Change: Communities to create integrated services for people with co-occurring disorders in the justice system. GAINS Center, Delmar , NY . 1999.

•  National Institute of Alcohol Abuse and Alcoholism. Helping patients who drink too much: a clinician's guide. NIAAA. 2005. www.niaaa.nih.gov/guide .

•  National Institute of Drug Abuse , The science of addiction, drugs, brains, behavior. www.drugabuse.gov . Rockville , MD , NIH Publication 07-5605 (2007)B

•  New Jersey Self-Help Clearinghouse. The self-help support group directory, 21 st Edition. 800-367-6274.

•  New York City Department of Health and Mental Hygiene. Quality Impact (Basic CQI course, addressing co-occurring disorders). www.nyc.gov/html/doh/html/qi/qi.shtml (2006)

•  Noether CD, Finkelstein N, et al. Design strengths and issues of SAMHSA's women, co-occurring disorders and violence study. Psych Services (2005) 56:1233-36.

•  Northeast Addiction Technology Transfer Center , Co-occurring Disorders in Adolescents: integrated assessment and treatment of the individual young person. www.neattc.org Erie , PA , NEATTC (2006)

•  Northeast Addiction Technology Transfer Center , Co-occurring Disorders in Adults. www.neattc.org Erie , PA , NEATTC (2006)

•  O'Brien C. Research advances in the understanding and treatment of addiction. Am J. Addict (2003) 12:536-47.

•  O'Brien, C. Anti-craving agents: a new category of psychotropic medications. American Journal of Psychiatry, 2005 162(8).

•  Ohio SAMI Coordinating Center of Excellence . Implementing IDDT: a step by step guide to organizational change. 2006. www.ohiosamiccoe.case.edu

•  Ohio SAMI Coordinating Center of Excellence . SAMI Matters. Fall 2007. Volume 5, No. 1. Transformation Continues. www.ohiosamiccoe.case.edu

•  Oklahoma Department of Mental Health and Substance Abuse Services. Change Agent Model Site Co-occurring Core L:evel Training. www.odmhsas.org (2006)

•  Padgett DK et al. Housing first services for people who are homeless with co-occurring serious mental illness and substance abuse. Res on SW Practice (2006). 15(1): 74-83.

•  Pennsylvania Department of Public Welfare and Department of Health. (2005) Co-occurring Disorder Capability Bulletin. Contact Rob Primrose at rprimrose@pa.state.us

•  Penn PE, et al. ADMIRE Plus: a treatment program for persons with co-occurring disorders. La Frontera Center : Tucson . 2004.

•  Peters RH & Bartoi, MG. Screening and Assessment of Co-occurring Disorders in the Justice System. National GAINS Center , Delmar , NY . 1997.

•  Petry NM et al. Contingency management interventions: from research to practice. Am J. Psychiat. (2001) 158:694-702.

•  Peters RH & Hills HA. Intervention strategies for offenders with co-occurring disorders. What works?. National GAINS Center , Delmar , NY . 1997.

•  Prochaska JO, DiClemente CC, Norcross JC. In search of how people change: applications to addictive behaviors. Am. Psychol. (1992) 47:1102-14.

•  Quinlivan R & McWhirter DP. Designing a comprehensive care program for high cost clients in a managed care environment. Psych Services (1996) 47:813-5.

•  RachBeisel, J, Scott, J. & Dixon, L. Co-occurring severe mental illness and substance use disorders: a review of recent research. Psych Services (1999). 50:1427-34.

•  Ray GT, et al. Relationship between use of psychiatric services and five year alcohol and drug treatment outcomes. Psych Services (2005) 56:164-71.

•  Regier, DA, Farmer ME, et. al.. Comorbidity of mental disorders with alcohol and other drug abuse. JAMA (1990) 264:2511-18.

•  Renner JA. Training psychiatrists to treat dual diagnosis patients. J. Dual Dx. (2007) 3: 125-136.

•  Ridgely, MS, Lambert, D, et. al.. Interagency collaboration in services for people with co-occurring mental illness and substance use disorder. Psych Services (1999) 49:236-8.

•  Ries, RK & Comtois KA. Illness severity and treatment services for dually diagnosed severely mentally ill outpatients. Schiz. Bull. (1997a) 23:239-46.

•  Ries, RK & Comtois KA. Managing disability benefits as part of treatment for persons with severe mental illness and comorbid substance disorder. Am. J. Addictions (1997b) 6(4):330-8.

•  Ries, RK, Russo, J, et. al.. Shorter hospital stays and more rapid improvement among patients with schizophrenia and substance disorders. Psych Services. 2001. 52(2):210-4.

•  Roberts LJ, Shaner A, & Eckman TA. Overcoming addictions: skills training for people with schizophrenia. W.W. Norton , New York . 1999.

•  Ronis RJ. The Ohio SAMI Coordinating Center of Excellence . J. Dual Dx (2004) 1(1):107-14.

•  Sacks, S. Co-occurring disorders: promising approaches and research issues. J. Substance Use & Misuse (2001).

•  Sacks, S, Sacks, JY, & DeLeon G. Treatment for MICAs: design and implementation of the modified TC. J. Psychoactive Drugs. (1999) 31:19-30.

•  Sacks, S, Sacks J, et al. Modified TC for MICA offenders: crime outcomes. Behav Sci & the Law (2004) 22:477-501.

•  SAMHSA. Position statement on use of block grant funds to treat people with co-occurring disorders. 2000

•  Sciacca, K. Dual Diagnosis website and articles. http://pobox.com/dualdiagnosis .

•  Scott CL, Lewis CF, &McDermott BE. Dual diagnosis among incarcerated populations: exception or rule? J. Dual Dx. (2006) 3:33-58

•  SMART Recovery. www.smartrecovery.org

•  Sowers W, et al. Level of care decision making in behavioral health services: the LOCUS and CALOCUS. Psych Services (2003) 54:1461-3.

•  Steadman H, et al. Validation of the brief jail mental health screen. Psych Services (2005): 56:816-22.

•  Steadman H & Naples M. Assessing the effectiveness of jail diversion programs for persons with SMI and SUD. Behav Sci & the Law (2005) 23:163-70.

•  Steinberg ML & Williams J. Psychosocial treatments for individuals with schizophrenia and tobacco dependence. J. Dual Dx. (2007) 3 (3/4:): 99-112.

•  Stuyt E & Meeker JL. Benefits of auricular acupuncture in tobacco free inpatient dual diagnosis treatment. J. Dual Dx. (2006) 2 (4): 41-52.

•  Substance Abuse and Mental Health Services Administration. Report to Congress on the Prevention and Treatment of Co-occurring Substance Abuse Disorders and Mental Disorders. November, 2002.

•  Substance Abuse and Mental Health Services Administration. Transforming MH Care in America . 2005. www.samhsa.gov .

•  Sciacca, K. Sciacca Comprehensive Service Development and Curriculum for MIDAA. Materials available on dual diagnosis website: http://pobox.com/~dualdiagnosis . E-mail. Ksciacca@pobox.com .

•  Shaner A, Eckman T, et al. Feasibility of a skills training approach to reduce substance dependence among individuals with schizophrenia. Psych Services (2003) 54:1287-9.

•  Shaner A, Roberts LJ, et. al.. Monetary reinforcement of abstinence from cocaine among mentally ill persons with cocaine dependence. Psych Services (1997) 48:807-10.

•  Smith, J. Co-Occurring Substance Abuse and Mental Disorders: A Practitioner's Guide. Jason Aronson, Lanham , MD. 2007.

•  Suncoast Practice and Research Collaborative (SPARC). Co-occurring Disorders Treatment Manual. Tampa : University of South Florida, Florida MH Institute. (2002) www.fmhi.usf.edu/mhlp/sparc/documents/manuals.htm .

•  Tracy EM & Biegel DE . Personal social networks and dual disorders: a literature review.. J. Dual Dx. (2006) 2(2): 59-83.

•  Tsemberis, S & Eisenberg, RF. Pathways to Housi-ng: Supported housing for street dwelling homeless individuals with psychiatric disabilities. Psych Services (2000). 51(4):487-95.

•  Tsemberis S, et al. Housing first, consumer choice, and harm reduction for homeless individuals with a dual diagnosis. Am J. Pub Health. (2004). 94:651-56.

•  University of South Florida , Florida Mental Health Institute. Co-occurring disorders: a training series for counselors (2003). http://cmhwbt.fmhi.usf.edu/home/program_info/cod_info.cfm . (Free on line curriculum)

•  Virginia DMHMRSAS. Substance abuse toolbox for primary care providers. 2004. Contact Mellie.Randall@co.dmhmrsas.va.gov

•  Weiss R, et. al.. Integrated dual recovery curriculum for bipolar disorder and addiction. McLean Hospital , Belmont , MA .

•  White WL, et al. It's time to stop kicking people out of addiction treatment. Counselor (April, 2005) 1-12.

•  Wieder BL et al. Adapting IDDT for inpatient settings. J. Dual Dx. (2005) 2(1):101-08.

•  Williams JM, Ziedonis D, et al. A case series of nicotine nasal spray in the treatment of tobacco dependence among patients with schizophrenia. Psych Services (2004) 55:1064-66.

•  Women for Sobriety. www.womenforsobriety.org

•  World Health Organization. ASSIST v.3.0 (Alcohol, Smoking, and Substance Involvement Screening Test). Geneva (2006)

•  Ziedonis D & Trudeau K. Motivation to quit using substances among individuals with schizophrenia: implications for a motivation-based treatment model. Schiz. Bull. (1997) 23:229-38.

•  Ziedonis D. Integrated treatment of co-occurring mental illness and addiction: clinical intervention, program, and system perspectives. CNS Spectrums (2004) 9:892-904.

•  Ziedonis D, Parks J, et al. Program and system level interventions to address tobacco among persons with schizophrenia. J. Dual Dx (2007) 3(3/4): 151-76

CO-OCCURRING DISORDER PSYCHOPHARMACOLOGY BIBLIOGRAPHY (2007)

•  Adelman S, Fletcher K, & Bahnassi A. Pharmacotherapeutic management strategies for mentally ill substance abusers. J. Subst. Abuse. Treatment. (1993) 10: 353-8.

•  Albanese M, Khantzian E, et. al.. Decreased substance use in chronically psychotic patients treated with clozapine. Am. J. Psych. (1994) 151:780-1.

•  American Psychiatric Association Steering Committee on Practice Guidelines. Treatment of patients with substance use disorders, 2 nd Ed. Am. J. Psychiat. (2007) 164 (4) Supp.

•  Anton RF, et al. Combined pharmacotherapies and behavioral interventions for alcohol dependence. JAMA (2006) 295:2003-17.

•  Batki SL et al. Monitored naltrexone without counseling for alcohol abuse/dependence in schizophrenia spectrum disorders. Am. J Addictions (2007) 16:253-59.

•  Biederman, J, Wilens, T, et. al.. Pharmacotherapy of ADHD reduces risk for substance use disorder. Pediatrics (1999).104(2).

•  Brady KT & Roberts J. The pharmacotherapy of dual diagnosis. Psych Annals (1995) 25:344-52.

•  Brunette MB , Noordsy DL, et al. Pharmacologic treatments for co-occurring sud in schizophrenia. J. Dual Dx. (2005) 1(2): 41-56.

•  Center For Substance Abuse Treatment. Clinical Guidelines for the use of buprenorphine.. Treatment Improvement Protocol #40. CSAT, Washington, 2005. www.ncadi.samhsa.gov . .

•  Ciraulo, DA & Nace, EP. Benzodiazepine treatment of anxiety or insomnia in substance abuse patients. Am. J. Addictions (2000) 9:276-84.

•  Cornelius JR, et al. Fluoxetine in adolescents with comorbid sud and major depression: a 5 year follow up study. J. Dual Dx. (2005) 2(1):11-26.

•  Fishman, SM. Responsible opioid prescribing: a physician's guide. Federation of State Medical Boards. Washington . Waterford Life Sciences. (2007).

•  Garbutt JC, et al. Efficacy and tolerability of long acting injectable naltrexone for alcohol dependence. JAMA (2005) 293:1617-25.

•  Green AI. Substance abuse and schizophrenia: pharmacologic approaches. J. Dual Dx. (2007) 3:63-72.

•  Kalivas, P & Volkow, N. Addiction: a brain disorder of motivation and choice. Am. J. Psych, Aug. 2005

•  Kleber. H. Pharmacologic treatments for heroin and cocaine dependence. Am. J. Addict. (2003) 12(Supp. 2): 5-18.

•  Kosten, TR. Management of anxiety in substance abusers. American Academy of Addiction Psychiatry Newsletter. Spring, 2000. AAAP, Prairie Village , KS

•  Minkoff K. CCISC Psychopharmacology Practice Guidelines. www.bhrm.org , 2005.

•  Montoya ID & Vocci F. Medications development for the treatment of nicotine dependence in individuals with schizophrenia. J. Dual Dx (2007) 3 (3/4) 113-50.

•  Mueser KT, Noordsy DL, & Essock S. Use of disulfiram in the treatment of patients with dual diagnosis. Am. J. Addictions (2001)

•  Myrick H & Wright T. Comorbid ansiety and substance use disorders: diagnostic and treatment considerations. J. Dual Dx. (2005) 1(4):9-23

•  Pettinati HM, et al. Gender differences in response to sertraline in Type A alcohol dependence. Am J. Addict. (2004) 13:236-247.

•  Posternak MA & Mueller TI. Assessing the risks and benefits of benxos for anxiety disorders in patients with a history of SUD. Am. J. Addict. (2001) 10:48-68.

•  Riggs PD & Davies RD. A clinical approach to integrating treatment for adolescent depression and substance abuse. J. Am Acad Child Adol Psychiat. (2002) 41(10)1-3.

•  Sowers, W & Golden, S. Psychotropic medication management in persons with co-occurring psychiatric and substance use disorders. J. Psychoactive Drugs. (1999) 31:59-67

•  Stein MD, et al. Persistence of antidepressant treatment effects in a pharmacotherapy plus psychotherapy trial for active injection drug users. Am. J. Addict. (2005) 14:346-57

•  O'Brien, C. Anti-craving agents: a new category of psychotropic medications. American Journal of Psychiatry, (2005) 162(8) 1423-31

•  Tollefson GD, Montague-Clouse J, & Tollefson SL. Treatment of comorbid generalized anxiety in a recently detoxified alcoholic population with a selective serotonergic drug (buspirone). J. Clin. Psychopharm. (1992) 12:19-26.

•  Wilens, TE, Spencer, TJ, et. al.. A controlled clinical trial of bupropion for adult ADHD. Am J. Psych (2001) 158:282-88.

•  Zimmet SV, Strous RD , et. al.. Effects of clozapine on substance use in patients with schizophrenia and schizoaffective disorders. J. Clin. Psychopharm (2000) 20:94-8.

DUAL DIAGNOSIS VIDEO MATERIALS

•  Promise of Recovery. Gerald T. Rogers Productions. 800-227-9100.

•  Double Trouble. Gerald T. Rogers Productions.

•  Out of the Tunnel; Into the Light. Hazelden. www.hazelden.org 800-328-9000.

•  12 Steps & Dual Disorders. Hazelden.

•  Dual Diagnosis.(1994) NIDA, Rockville , MD. www.drugabuse.gov .

•  Understanding Bipolar Disorder and Addiction (Dual Diagnosis Series), Hazelden www.hazelden.org

•  Understanding Depression and Addiction

•  Understanding Major Anxiety Disorders and Addiction

•  Understanding Personality Problems and Addiction

•  Understanding Posttraumatic Stress Disorder and Addiction.

•  Dual Diagnosis: An Integrated Model for Treatment. Kenneth Minkoff, MD. Mental Illness Education Project. 800-343-5540. www.miepvideos.org

•  Recovery Stories, DVD or VHS, (Co-Occurring Consumer Stories) CCSME/NAMI Maine, 207-878-6170, www.ccsme.org